Molecular medicine: a primer for clinicians. Part XIV: Stem cells.

S D J Med

Divison of Basic Biomedical Sciences, USD School of Medicine, Vermillion, SD, USA.

Published: February 2004

Earlier papers in this series have described many of the tools of molecular biology that are finding practical bedside applications. We have reviewed how molecular diagnostics, genetic testing, and DNA and protein microarrays all have become part of clinical medicine. We have also described the potential of the human genome project to impact the practice of medicine. Finally, we have discussed several ethical issues, including genetic screening, forensic DNA testing, and gene therapy. In this paper, and the next, we will discuss two topical areas in which molecular biology may influence how medicine is practiced in the future; stem cell research and cloning technology.

Download full-text PDF

Source

Publication Analysis

Top Keywords

molecular biology
8
molecular
4
molecular medicine
4
medicine primer
4
primer clinicians
4
clinicians xiv
4
xiv stem
4
stem cells
4
cells earlier
4
earlier papers
4

Similar Publications

Depot-specific acetylation profiles of adipose tissues-therapeutic targets for metabolically unhealthy obesity.

Diabetol Metab Syndr

January 2025

The Centre for Cleft Lip and Palate Treatment, Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 33 Badachu Road, Shijingshan District, Beijing, 100144, People's Republic of China.

Background: Adipose tissue plays a critical role in the development of metabolically unhealthy obesity (MUO), with distinct adipose depots demonstrating functional differences. This study aimed to investigate the unique characteristics of subcutaneous (SA) and visceral adipose tissue (VA) in MUO.

Methods: Paired omental VA and abdominal SA samples were obtained from four male patients with MUO and subjected to Four-Dimensional Data Independent Acquisition (4D-DIA) proteomic and lysine acetylation (Kac) analyses.

View Article and Find Full Text PDF

Many diseases and disorders of the nervous system suffer from a lack of adequate therapeutics to halt or slow disease progression, and to this day, no cure exists for any of the fatal neurodegenerative diseases. In part this is due to the incredible diversity of cell types that comprise the brain, knowledge gaps in understanding basic mechanisms of disease, as well as a lack of reliable strategies for delivering new therapeutic modalities to affected areas. With the advent of single cell genomics, it is now possible to interrogate the molecular characteristics of diverse cell populations and their alterations in diseased states.

View Article and Find Full Text PDF

Sex reversal induced by 17β-estradiol may be achieved by regulating the neuroendocrine system of the Pacific white shrimp Penaeus vannamei.

BMC Genomics

January 2025

Key Laboratory of Breeding Biotechnology and Sustainable Aquaculture, Institute of Oceanology, Chinese Academy of Sciences, Qingdao, China.

Background: Due to sexual dimorphism in growth of penaeid shrimp, all-female cultivation is desirable for the aquaculture industry. 17β-estradiol (E2) has the potential to induce the male-to-female sex reversal of decapod species. However, the mechanisms behind it remain poorly understood.

View Article and Find Full Text PDF

Mechanistic insights and approaches for beta cell regeneration.

Nat Chem Biol

January 2025

Department of Medical Cell Biology, Uppsala University, Biomedical Centre, Uppsala, Sweden.

Diabetes is characterized by variable loss of insulin-producing beta cells, and new regenerative approaches to increasing the functional beta cell mass of patients hold promise for reversing disease progression. In this Review, we summarize recent chemical biology breakthroughs advancing our knowledge of beta cell regeneration. We present current chemical-based tools, sensors and mechanistic insights into pathways that can be targeted to enhance beta cell regeneration in model organisms.

View Article and Find Full Text PDF

Hsa_circ_0001304 promotes vascular neointimal hyperplasia accompanied by autophagy activation.

Commun Biol

January 2025

Department of Biochemistry and Molecular Biology, Key Laboratory of Neural and Vascular Biology, Ministry of Education, Hebei Key Laboratory of Forensic Medicine, Hebei Medical University, Shijiazhuang, 050017, China.

Aberrant autophagy in vascular smooth muscle cells (VSMCs) is associated with the progression of vascular remodeling diseases caused by neointimal hyperplasia. Platelet-derived growth factor-BB (PDGF-BB)-induced vascular remodeling is accompanied by autophagy activation, however, the involvement of circular RNAs (circRNAs) remains unclear. Here, we show the role of PDGF-BB-regulated hsa_circ_0001304 (circ-1304) in neointimal hyperplasia and its potential involvement in VSMC autophagy, while also elucidating the potential mechanisms.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!